These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12018674)

  • 1. Relapse of thrombotic thrombocytopenic purpura associated with decreased VWF cleaving activity.
    Anstadt MP; Carwile JM; Guill CK; Conklin LD; Soltero ER; Lucci A; Kroll MH
    Am J Med Sci; 2002 May; 323(5):281-4. PubMed ID: 12018674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor and thrombotic thrombocytopenic purpura.
    Raife TJ; Montgomery RR
    Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
    Moake JL
    Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL
    Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
    Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
    Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
    Yoo G; Blombäck M; Schenck-Gustafsson K; He S
    Br J Haematol; 2003 Apr; 121(1):123-9. PubMed ID: 12670342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB; Mayfield CA; Blackall DP
    Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
    Yagi H
    Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
    Chow TW; Turner NA; Chintagumpala M; McPherson PD; Nolasco LH; Rice L; Hellums JD; Moake JL
    Am J Hematol; 1998 Apr; 57(4):293-302. PubMed ID: 9544973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopaenic purpura in HIV-infected patients.
    Miller RF; Scully M; Cohen H; Roedling S; Starke R; Edwards SG; Machin SJ
    Int J STD AIDS; 2005 Aug; 16(8):538-42. PubMed ID: 16105187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
    Moake JL
    Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The changing paradigm of thrombotic thrombocytopenic purpura.
    Raife TJ
    Semin Thromb Hemost; 2005 Dec; 31(6):641-51. PubMed ID: 16388415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.
    Allford SL; Harrison P; Lawrie AS; Liesner R; MacKie IJ; Machin SJ
    Br J Haematol; 2000 Dec; 111(4):1215-22. PubMed ID: 11167764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.